<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03352167</url>
  </required_header>
  <id_info>
    <org_study_id>SHS-ED-11-2017</org_study_id>
    <nct_id>NCT03352167</nct_id>
  </id_info>
  <brief_title>Antibiotic Resistance in Danish EDs.</brief_title>
  <acronym>AB-RED</acronym>
  <official_title>Antibiotic Resistance in Danish Emergency Departments. Prevalence, Risk Factors and Definition of Risk Groups.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Southern Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Southern Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The spread of multiresistant bacteria is an increasing problem which will mean increased&#xD;
      costs, morbidity and mortality in the coming years. Emergency departments (ED) play a key&#xD;
      role in the early identification and management of patients who are carriers of&#xD;
      multiresistant bacteria, but today there is very limited knowledge about both prevalence in&#xD;
      the EDs and risk factors for the carrier status of methicillin resistant Staphylococcus&#xD;
      aureus (MRSA), extended spectrum beta lactam producing enterobacteria (ESBL), vancomycin&#xD;
      resistant enterococci (VRE), carbapenem resistant enterobacteria (CPE) and toxin-producing&#xD;
      Clostridium difficile (CD). This knowledge is necessary to prioritize and target the&#xD;
      preventive response to the spread of multiresistant bacteria.&#xD;
&#xD;
      The aim of this project is to provide a comprehensive overview of prevalence and risk factors&#xD;
      for carrier status at a national level, and to develop screening tools for early&#xD;
      identification of MRSA, ESBL, VRE, CPE and CD carriers among patients admitted to Danish&#xD;
      emergency departments.&#xD;
&#xD;
      For hospitalized patients in 8 emergency departments in 4 Danish regions, a total of 10,600&#xD;
      patients are asked for possible risk factors for resistant bacterial carrier status, and are&#xD;
      swabbed in the throat, nose and rectum openings and examined for MRSA, VRE, CPE, ESBL and CD&#xD;
      with the same analytical method of 4 clinical microbiological departments.&#xD;
&#xD;
      The results are analyzed so that the prevalence of resistant bacteria can be described at the&#xD;
      hospital level, regional level and national level. Risk factors are analyzed for&#xD;
      applicability for carrier identification, and based on this, screening models for the&#xD;
      identification of carriers are developed.&#xD;
&#xD;
      The vision for the project is that, based on the collected data, a comprehensive picture of&#xD;
      the extent of the problem in Denmark can be drawn up and new screening tools for early&#xD;
      identification of carriers can be developed so that the intra-hospital spread of resistant&#xD;
      bacteria can be met through early intervention with infectious hygiene measures.&#xD;
&#xD;
      The project has been granted a grant of DKK 3,000,000 from the Ministry of Health and the&#xD;
      Elderly on December 7, 2016 and DKK 554,871 from the Region of Southern Denmark on 28 August&#xD;
      2017.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 8, 2018</start_date>
  <completion_date type="Actual">July 1, 2018</completion_date>
  <primary_completion_date type="Actual">May 1, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>4 Months</target_duration>
  <primary_outcome>
    <measure>Bacterial Antibiotic Resistance</measure>
    <time_frame>baseline observation only</time_frame>
  </primary_outcome>
  <number_of_groups>8</number_of_groups>
  <enrollment type="Actual">5117</enrollment>
  <condition>Antibiotic Resistance, Bacterial</condition>
  <arm_group>
    <arm_group_label>ED Hjoerring</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ED Aalborg</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ED Aarhus</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ED Herning</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ED Aabenraa</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ED Odense</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ED Slagelse</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>ED Koege</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      swabs from nose, throat and rectum for analysis of bacterial DNA&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        all patients more than 18 years of age admitted for any reason to one of the participating&#xD;
        Emergency Departments&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  Must be over 18 years&#xD;
&#xD;
          -  Must be admitted to one of the emergency departments selected for the project for more&#xD;
             than 4 hours.&#xD;
&#xD;
          -  Must be mentally competent&#xD;
&#xD;
          -  To consent to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  admitted more than 16 hours before inclusion&#xD;
&#xD;
          -  no operation in rectum less than 2 weeks before the admission&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital of Southern Jutland</name>
      <address>
        <city>Aabenraa</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aalborg University Hospital</name>
      <address>
        <city>Aalborg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aarhus Univerisity Hospital</name>
      <address>
        <city>Aarhus</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herning Hospital</name>
      <address>
        <city>Herning</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hjørring Hospital</name>
      <address>
        <city>Hjørring</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Køge University Hospital</name>
      <address>
        <city>Køge</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Slagelse Hospital</name>
      <address>
        <city>Slagelse</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>November 20, 2017</study_first_submitted>
  <study_first_submitted_qc>November 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2017</study_first_posted>
  <last_update_submitted>May 25, 2021</last_update_submitted>
  <last_update_submitted_qc>May 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Southern Denmark</investigator_affiliation>
    <investigator_full_name>Christian Backer Mogensen</investigator_full_name>
    <investigator_title>ass. professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

